Popular Articles

Insurers Offer Reform Concessions, But Balk At Small Business Demands
"Employer-provided medical insurance remains the bedrock of the nation"s health care system. And yet, while most big employers still provide health benefits, soaring premiums have meant many small businesses can no longer afford to cover their workers," the New York Times reports. Some are concerned that many such businesses, those with fewer than 100 workers and which employ 40 percent of the labor force, will be left out of the health reform plan incubating in Congress. While insurers have offered key concessions to make it easier for individuals to buy insurance, saying they"ll "sell policies even to people with pre-existing medical conditions, and to stop basing prices on how healthy or sick someone is," the companies appear unwilling to give small employers the same break.

Perceiving Touch And Your Self Outside Of Your Body: Altering Bodily Self-Consciousness And Touch Perception Via The Full Body Illusion
When you feel you are being touched, usually someone or something is
News of the day
New Data From Satraplatin Phase 3 Trial In Second-Line Castrate-Refractory Prostate Cancer Presented At 2009 ASCO Annual Meeting
GPC Biotech AG (FRANKFURT: GPC) (XETRA: GPC) announced that data from the double- blind, randomized satraplatin Phase 3 trial, the SPARC trial (Satraplatin and Prednisone Against Refractory Cancer), were presented at the 2009 American Society for Clinical Oncology (ASCO) Annual Meeting in Orlando, Florida. The SPARC trial evaluated satraplatin plus prednisone versus placebo plus prednisone in 950 patients with castrate-refractory prostate cancer (CRPC) who had progressed after initial chemotherapy. The data presented are retrospective analyses of the SPARC trial evaluating correlations between overall survival (OS) and pain at baseline, pain progression, and progression-free survival (PFS) at three months.
Oncology

We Must Lead The NHS Through "dark And Dangerous Period", Says British Medical Association Consultant Chairman

The health service is entering a "dark and dangerous period" because of the economic crisis, the Chairman of the BMA"s Consultants Committee warned in a speech. Arguing that public money must not be diverted away from patient care into "the pockets of shareholders", Dr Jonathan Fielden called for private management consultants to be "ditched" from the NHS. Addressing the BMA"s annual Consultants Conference, Dr Fielden celebrated successes in the NHS while condemning "aberrant corporate cultures" in some hospitals, which had led to "painful blots on the NHS landscape" such as substandard care at Stafford Hospital. "Waiting times are at an all time low, survival rates are increasing, patient experience is improving. Our hospitals are cleaner, safer and better than ever before," he said. "However, there have been clear failings where patients have not received the high quality care they deserved, where the processes, systems and sometimes individuals have let them down. Painful, dreadful blots on the NHS landscape, where patient care has suffered. "In each of these there is a common theme: targets being put in front of quality, staff not being listened to, aberrant corporate cultures suppressing concerns and disregarding safety. Doctors must challenge this culture of denial and lead a better way forward." Dr Fielden announced the results of a BMA survey indicating that three quarters (74%) of hospital doctors had had concerns about issues relating to patient safety, malpractice or bullying, over the course of their careers. Seven in ten (70%) of these had raised the issues at their trust, but their experiences had often been negative, for example because they were unaware that anything had happened as a result (46%) or their trusts had indicated that by speaking up, their employment could be negatively affected (15.5%). And in a criticism of the ÷£350 million reportedly spent on independent management consultants in the English NHS last year, Dr Fielden said NHS doctors were motivated by different incentives: "Let more money remain in the NHS - hard-earned taxpayers" money going where they want it - into patient care, not the pockets of shareholders. It is the ethos, the faith that is at the heart of the Health Service that drives us. One that management consultants, brought up in the tarnished world of finance fail to understand. "Ditch the external management consultants - when we see them flogging our ideas, there is palpable frustration that we are not utilising the great talents across the NHS." "For the first time in working memory, we may see real cuts in health spending. This will provoke some stark choices: what is kept, what is cut, what can the NHS afford? Let"s ensure that it"s doctors making those difficult decisions in partnership with our patients and healthcare colleagues, not faceless bureaucrats, accountants, and those out to fleece the taxpayer." Identifying further areas where savings might be made, he criticised the amount paid to Independent Sector Treatment Centres for work that was not carried out, as much as ÷£927 million in England according to an estimate in a recent study, as "a dangerous waste." And he called for the current ÷£1.7 billion surplus in the NHS to be reinvested in patient care: "It has been hard-earned and our patients need it. The treasury must not pilfer this coffer. NHS money is for NHS patients." Links 1. The full text of the speech 2. BMA"s survey on whistle-blowing 3. "Look After Our NHS" initiative that was launched to gather examples of the impact of market reforms on the NHS The British Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):